Calcium in PDB 4btw: Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
Enzymatic activity of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
All present enzymatic activity of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors:
1.4.3.21;
Protein crystallography data
The structure of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors, PDB code: 4btw
was solved by
E.Bligt-Linden,
M.Pihlavisto,
I.Szatmari,
Z.Otwinowski,
D.J.Smith,
L.Lazar,
F.Fulop,
T.A.Salminen,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
49.39 /
2.80
|
Space group
|
P 65 2 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
226.473,
226.473,
219.250,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
20.504 /
26.032
|
Other elements in 4btw:
The structure of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors also contains other interesting chemical elements:
Calcium Binding Sites:
The binding sites of Calcium atom in the Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
(pdb code 4btw). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 4 binding sites of Calcium where determined in the
Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors, PDB code: 4btw:
Jump to Calcium binding site number:
1;
2;
3;
4;
Calcium binding site 1 out
of 4 in 4btw
Go back to
Calcium Binding Sites List in 4btw
Calcium binding site 1 out
of 4 in the Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
 Mono view
 Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca1763
b:52.0
occ:1.00
|
O
|
A:LEU530
|
2.3
|
42.1
|
1.0
|
OD1
|
A:ASP531
|
2.3
|
49.3
|
1.0
|
OD1
|
A:ASP673
|
2.3
|
48.5
|
1.0
|
N
|
A:LEU674
|
2.3
|
57.0
|
1.0
|
O
|
A:LEU674
|
2.3
|
53.9
|
1.0
|
OD1
|
A:ASP529
|
2.4
|
56.4
|
1.0
|
C
|
A:LEU674
|
3.1
|
49.8
|
1.0
|
C
|
A:ASP673
|
3.2
|
60.0
|
1.0
|
CA
|
A:LEU674
|
3.2
|
52.1
|
1.0
|
CG
|
A:ASP673
|
3.4
|
52.6
|
1.0
|
C
|
A:LEU530
|
3.5
|
49.5
|
1.0
|
CA
|
A:ASP673
|
3.5
|
58.6
|
1.0
|
CG
|
A:ASP531
|
3.5
|
49.5
|
1.0
|
CG
|
A:ASP529
|
3.7
|
56.0
|
1.0
|
ND2
|
A:ASN537
|
3.9
|
45.2
|
1.0
|
CB
|
A:ASP673
|
4.0
|
56.6
|
1.0
|
NZ
|
A:LYS106
|
4.1
|
48.2
|
1.0
|
O
|
A:LEU535
|
4.1
|
58.5
|
1.0
|
CB
|
A:LEU674
|
4.1
|
52.9
|
1.0
|
CA
|
A:ASP531
|
4.2
|
48.5
|
1.0
|
N
|
A:VAL675
|
4.2
|
48.7
|
1.0
|
O
|
A:ASP673
|
4.3
|
55.6
|
1.0
|
N
|
A:ASP531
|
4.3
|
51.1
|
1.0
|
OD2
|
A:ASP531
|
4.4
|
44.4
|
1.0
|
OD2
|
A:ASP529
|
4.4
|
53.1
|
1.0
|
OD2
|
A:ASP673
|
4.4
|
51.9
|
1.0
|
CB
|
A:ASP531
|
4.5
|
50.3
|
1.0
|
N
|
A:LEU530
|
4.5
|
51.1
|
1.0
|
C
|
A:ASP529
|
4.5
|
50.2
|
1.0
|
CA
|
A:LEU530
|
4.7
|
50.1
|
1.0
|
O
|
A:LYS672
|
4.7
|
61.2
|
1.0
|
CA
|
A:ASP529
|
4.7
|
51.6
|
1.0
|
CB
|
A:ASP529
|
4.8
|
53.9
|
1.0
|
N
|
A:ASP673
|
4.8
|
55.8
|
1.0
|
CA
|
A:VAL675
|
4.9
|
49.4
|
1.0
|
CB
|
A:ARG637
|
4.9
|
56.5
|
1.0
|
O
|
A:ASP529
|
4.9
|
53.2
|
1.0
|
|
Calcium binding site 2 out
of 4 in 4btw
Go back to
Calcium Binding Sites List in 4btw
Calcium binding site 2 out
of 4 in the Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
 Mono view
 Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca1764
b:59.8
occ:1.00
|
OE1
|
A:GLU667
|
2.3
|
62.6
|
1.0
|
O
|
A:PHE663
|
2.3
|
61.3
|
1.0
|
OD1
|
A:ASN665
|
2.4
|
59.1
|
1.0
|
OE2
|
A:GLU572
|
2.4
|
54.0
|
1.0
|
OE1
|
A:GLU572
|
2.4
|
51.4
|
1.0
|
CD
|
A:GLU572
|
2.8
|
50.3
|
1.0
|
C
|
A:PHE663
|
3.4
|
54.4
|
1.0
|
CG
|
A:ASN665
|
3.5
|
59.5
|
1.0
|
CD
|
A:GLU667
|
3.5
|
65.0
|
1.0
|
OE1
|
A:GLU641
|
3.7
|
50.9
|
1.0
|
NZ
|
A:LYS638
|
3.7
|
56.8
|
1.0
|
ND2
|
A:ASN665
|
3.9
|
62.3
|
1.0
|
CA
|
A:PHE663
|
4.1
|
53.0
|
1.0
|
OE2
|
A:GLU667
|
4.2
|
61.5
|
1.0
|
OE2
|
A:GLU641
|
4.3
|
54.6
|
1.0
|
CG
|
A:GLU572
|
4.3
|
48.8
|
1.0
|
CG2
|
A:THR635
|
4.3
|
53.7
|
1.0
|
CB
|
A:THR635
|
4.4
|
53.6
|
1.0
|
O
|
A:GLN636
|
4.4
|
68.5
|
1.0
|
CD
|
A:GLU641
|
4.4
|
53.1
|
1.0
|
N
|
A:ILE664
|
4.4
|
57.0
|
1.0
|
N
|
A:GLN636
|
4.5
|
65.2
|
1.0
|
N
|
A:ASN665
|
4.5
|
63.4
|
1.0
|
CB
|
A:GLN636
|
4.5
|
59.8
|
1.0
|
CG
|
A:GLU667
|
4.5
|
68.9
|
1.0
|
CB
|
A:GLU667
|
4.6
|
68.5
|
1.0
|
CA
|
A:ILE664
|
4.7
|
56.2
|
1.0
|
CB
|
A:PHE663
|
4.8
|
53.8
|
1.0
|
CB
|
A:ASN665
|
4.8
|
57.7
|
1.0
|
O
|
A:ASP662
|
4.9
|
49.5
|
1.0
|
O
|
A:ASN665
|
4.9
|
70.3
|
1.0
|
CA
|
A:GLN636
|
5.0
|
63.9
|
1.0
|
|
Calcium binding site 3 out
of 4 in 4btw
Go back to
Calcium Binding Sites List in 4btw
Calcium binding site 3 out
of 4 in the Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
 Mono view
 Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca1763
b:51.0
occ:1.00
|
O
|
B:LEU674
|
2.3
|
47.5
|
1.0
|
OD1
|
B:ASP673
|
2.3
|
43.8
|
1.0
|
OD1
|
B:ASP531
|
2.3
|
48.9
|
1.0
|
O
|
B:LEU530
|
2.3
|
56.9
|
1.0
|
OD1
|
B:ASP529
|
2.3
|
48.2
|
1.0
|
C
|
B:LEU530
|
3.4
|
56.3
|
1.0
|
N
|
B:LEU674
|
3.4
|
46.5
|
1.0
|
C
|
B:LEU674
|
3.4
|
47.2
|
1.0
|
CG
|
B:ASP673
|
3.5
|
40.8
|
1.0
|
CG
|
B:ASP531
|
3.5
|
51.1
|
1.0
|
CG
|
B:ASP529
|
3.6
|
56.3
|
1.0
|
ND2
|
B:ASN537
|
3.6
|
62.2
|
1.0
|
NZ
|
B:LYS106
|
3.7
|
37.2
|
1.0
|
C
|
B:ASP673
|
3.9
|
43.0
|
1.0
|
CA
|
B:LEU674
|
3.9
|
44.4
|
1.0
|
N
|
B:ASP531
|
4.0
|
56.6
|
1.0
|
CA
|
B:ASP531
|
4.1
|
50.8
|
1.0
|
CA
|
B:ASP673
|
4.2
|
44.1
|
1.0
|
OD2
|
B:ASP529
|
4.2
|
55.7
|
1.0
|
OD2
|
B:ASP673
|
4.2
|
40.8
|
1.0
|
C
|
B:ASP529
|
4.3
|
50.5
|
1.0
|
N
|
B:LEU530
|
4.3
|
49.7
|
1.0
|
CB
|
B:ASP531
|
4.4
|
49.9
|
1.0
|
O
|
B:LEU535
|
4.4
|
57.8
|
1.0
|
CB
|
B:ASP673
|
4.4
|
42.7
|
1.0
|
CA
|
B:LEU530
|
4.5
|
52.4
|
1.0
|
OD2
|
B:ASP531
|
4.5
|
54.2
|
1.0
|
N
|
B:VAL675
|
4.6
|
47.0
|
1.0
|
CA
|
B:ASP529
|
4.6
|
50.4
|
1.0
|
O
|
B:ASP673
|
4.6
|
43.4
|
1.0
|
O
|
B:ASP529
|
4.7
|
51.1
|
1.0
|
CB
|
B:ASP529
|
4.7
|
56.2
|
1.0
|
CB
|
B:LEU674
|
4.8
|
43.8
|
1.0
|
CA
|
B:VAL675
|
5.0
|
48.8
|
1.0
|
CG
|
B:ASN537
|
5.0
|
57.2
|
1.0
|
|
Calcium binding site 4 out
of 4 in 4btw
Go back to
Calcium Binding Sites List in 4btw
Calcium binding site 4 out
of 4 in the Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
 Mono view
 Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 4 of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca1764
b:60.5
occ:1.00
|
OE1
|
B:GLU667
|
2.3
|
55.6
|
1.0
|
O
|
B:PHE663
|
2.3
|
55.5
|
1.0
|
OE2
|
B:GLU572
|
2.4
|
58.7
|
1.0
|
OD1
|
B:ASN665
|
2.4
|
67.4
|
1.0
|
OE2
|
B:GLU641
|
2.4
|
65.7
|
1.0
|
OE1
|
B:GLU572
|
2.4
|
49.8
|
1.0
|
CD
|
B:GLU572
|
2.8
|
52.6
|
1.0
|
NZ
|
B:LYS638
|
3.3
|
49.1
|
1.0
|
CD
|
B:GLU641
|
3.4
|
65.6
|
1.0
|
CG
|
B:ASN665
|
3.4
|
56.6
|
1.0
|
C
|
B:PHE663
|
3.5
|
50.7
|
1.0
|
CD
|
B:GLU667
|
3.5
|
50.1
|
1.0
|
OE1
|
B:GLU641
|
3.5
|
73.6
|
1.0
|
ND2
|
B:ASN665
|
3.9
|
56.9
|
1.0
|
OE2
|
B:GLU667
|
4.0
|
49.1
|
1.0
|
CA
|
B:PHE663
|
4.1
|
53.6
|
1.0
|
CG
|
B:GLU572
|
4.3
|
47.4
|
1.0
|
CB
|
B:THR635
|
4.5
|
50.1
|
1.0
|
N
|
B:ASN665
|
4.5
|
58.6
|
1.0
|
N
|
B:ILE664
|
4.5
|
50.6
|
1.0
|
CE
|
B:LYS638
|
4.6
|
52.9
|
1.0
|
CG
|
B:GLU667
|
4.6
|
47.9
|
1.0
|
N
|
B:GLN636
|
4.6
|
50.9
|
1.0
|
CD
|
B:LYS638
|
4.7
|
55.1
|
1.0
|
O
|
B:GLN636
|
4.7
|
55.8
|
1.0
|
CB
|
B:ASN665
|
4.7
|
52.1
|
1.0
|
CA
|
B:ILE664
|
4.8
|
55.2
|
1.0
|
CB
|
B:GLU667
|
4.8
|
46.5
|
1.0
|
O
|
B:ASP662
|
4.8
|
76.7
|
1.0
|
CB
|
B:PHE663
|
4.9
|
53.5
|
1.0
|
CG
|
B:GLU641
|
4.9
|
52.0
|
1.0
|
C
|
B:ILE664
|
5.0
|
59.2
|
1.0
|
|
Reference:
E.Bligt-Linden,
M.Pihlavisto,
I.Szatmari,
Z.Otwinowski,
D.J.Smith,
L.Lazar,
F.Fulop,
T.A.Salminen.
Novel Pyridazinone Inhibitors For Vascular Adhesion Protein- 1 (Vap-1): Old Target - New Inhibition Mode. J.Med.Chem. V. 56 9837 2013.
ISSN: ISSN 0022-2623
PubMed: 24304424
DOI: 10.1021/JM401372D
Page generated: Sat Jul 13 22:49:42 2024
|